Sign Up for a Free Account
  • Updated 02.19.2024
  • Released 08.17.1995
  • Expires For CME 02.19.2027

Headache associated with acute substance use or exposure



Substance headache is a headache that develops de novo with the use or exposure of a substance. The clinical manifestations of substance-induced headache are variable. In this article, the authors update the current evidence regarding the clinical manifestations and pathophysiology of headache associated with the acute use or exposure of certain substances, with specific focus on nitric oxide donor, and carbon monoxide and calcitonin gene-related peptide, which provides a better understanding of headache biology.

Key points

• The clinical manifestations of headache associated with the use or exposure of substances are variable.

• Headache attributed to substances is currently placed under Section 8 of the International Classification of Headache Disorders, 3rd edition (2018).

• Nitric oxide and calcitonin gene-related peptides are crucial components in the pathophysiology of primary headache disorders, and they have been used to experimentally trigger headache attacks.

• Alcohol, cocaine, and histamine can cause immediate headache after exposure and delayed headache in predisposed individuals. Subjects vulnerable to alcohol-induced headache could have a genetic predisposition.

Historical note and terminology

The codification of headache diagnosis by the International Headache Society in 1988 had a considerable impact on the study and understanding of headache (17). The second edition of the classification revised section 8: headache attributed to a substance or its withdrawal (18), and the definition was slightly modified in the third edition of the International Classification of Headache Disorders (ICHD-3) (19). When a headache occurs de novo in close temporal relation to the exposure of a substance, it remains true to code, the headache as a secondary headache attributed to exposure to that substance. However, when there is a pre-existing headache with characteristics of a primary headache disorder and that headache becomes chronic or worsens significantly in close temporal relation to exposure to a substance, both the initial headache diagnosis and a diagnosis of “Headache attributed to a substance” should be given.

This article deals with section 8.1 headache attributed to use of or exposure to a substance of the IHCD-3 and includes a discussion about clinical manifestations and pathophysiological mechanisms of: 8.1.1 nitric oxide (NO) donor-induced headache, 8.1.2 phosphodiesterase (PDE) inhibitor-induced headache, 8.1.3 carbon monoxide (CO)-induced headache, 8.1.4 alcohol-induced headache, 8.1.5 cocaine-induced headache, 8.1.6 histamine-induced headache, and 8.1.7 calcitonin gene-related peptide (CGRP)-induced headache. In this review, we do not cover 8.2 medication overuse headache, or 8.3 headache attributed to substance withdrawal.

This is an article preview.
Start a Free Account
to access the full version.

  • Nearly 3,000 illustrations, including video clips of neurologic disorders.

  • Every article is reviewed by our esteemed Editorial Board for accuracy and currency.

  • Full spectrum of neurology in 1,200 comprehensive articles.

  • Listen to MedLink on the go with Audio versions of each article.

Questions or Comment?

MedLink®, LLC

3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122

Toll Free (U.S. + Canada): 800-452-2400

US Number: +1-619-640-4660



ISSN: 2831-9125